IBIO stock news · iBio

Stories about iBio (IBIO) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for IBIO

Follow iBio (IBIO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Oct 20, 2026, 1:11 PM ET · Market
On Tuesday, 12 health care stocks saw big price changes during the day.
Neutral
iBio shares rose about 17%, but the article gives no business update or reason for the move. The share-price change alone does not alter the company's outlook.
Oct 19, 2026, 4:23 PM ET · Market
iBio, Inc. says some directors and officers are leaving, while new ones are being chosen and hired.
Bad for IBIO
iBio's shareholders approved a larger pool of authorized shares and future additions to its stock-pay plan. This gives the company more room to issue shares, which could shrink existing owners' stakes.
Oct 13, 2026, 9:23 AM ET · Market
iBio, Inc. shares new information about its weight loss treatment, IBIO-610, and its use with semaglutide.
Good for IBIO
iBio’s monkey study found more weight loss came from fat with IBIO-610 plus semaglutide than with semaglutide alone. This supports the drug’s promise, but people have not been tested.